This trial is testing whether using brain network connectivity patterns can help optimize outcomes from rTMS treatment for depression.
1 Primary · 3 Secondary · Reporting Duration: Baseline and 1 Week Post Treatment (8-10 weeks)
Active Control
Experimental Treatment
348 Total Participants · 3 Treatment Groups
Primary Treatment: Repetitive Transcranial Magnetic Stimulation · No Placebo Group · Phase 3
Age 22 - 65 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:New York | 70.0% |
New Jersey | 20.0% |
Wisconsin | 10.0% |
18 - 65 | 100.0% |
Weill Cornell Medicine | 100.0% |
Met criteria | 90.0% |
Did not meet criteria | 10.0% |
Phone Call | 25.0% |
75.0% | |